Filter Results:
(3,165)
Show Results For
- All HBS Web
(3,165)
- People (17)
- News (867)
- Research (1,551)
- Events (20)
- Multimedia (13)
- Faculty Publications (718)
Show Results For
- All HBS Web
(3,165)
- People (17)
- News (867)
- Research (1,551)
- Events (20)
- Multimedia (13)
- Faculty Publications (718)
- 19 Oct 2018
- News
Lessons from Mayo Clinic’s Redesign of Stroke Care
- 12 Feb 2025
- Video
Beyond traditional ownership: Capitalism's next chapter
- Article
Big Names or Big Ideas: Do Peer-Review Panels Select the Best Science Proposals?
By: Danielle Li and Leila Agha
This paper examines the success of peer-review panels in predicting the future quality of proposed research. We construct new data to track publication, citation, and patenting outcomes associated with more than 130,000 research project (R01) grants funded by the U.S.... View Details
Keywords: Patents; Research; Entrepreneurship; Forecasting and Prediction; Innovation and Invention; Business and Government Relations; United States
Li, Danielle, and Leila Agha. "Big Names or Big Ideas: Do Peer-Review Panels Select the Best Science Proposals?" Science 348, no. 6233 (April 24, 2015): 434–438.
Cameron Deal
Cameron studies health economics and economic history, with a focus on LGBTQ populations and inequality. His research has specifically examined health risk and access disparities, youth homelessness, intergenerational mobility, and the effects of health policies on... View Details
- September 2022
- Article
Find and Replace: R&D Investment Following the Erosion of Existing Products
By: Joshua L. Krieger, Xuelin Li and Richard T. Thakor
How do innovative firms react when existing products experience negative shocks? We explore this question with detailed project-level data from drug development firms. Using FDA Public Health Advisories as idiosyncratic negative shocks to approved drugs, we first... View Details
Keywords: R＆D Investments; Drug Development; Product Shocks; M＆A; Biopharmaceutical Industry; FDA; System Shocks; Research and Development; Investment; Decision Making; Pharmaceutical Industry
Krieger, Joshua L., Xuelin Li, and Richard T. Thakor. "Find and Replace: R&D Investment Following the Erosion of Existing Products." Management Science 68, no. 9 (September 2022): 6552–6571.
- October 22, 2015
- Article
The Mayo Clinic Model for Running a Value-Improvement Program
By: Robert S. Kaplan, Derek A. Haas, Richard A. Helmers, March Rucci and Meredith Brady
Applying time-driven activity-based costing (TDABC) in health care cannot be delegated to the finance function. The most successful implementations have had strong executive support, exceptional clinical leaders, and dedicated, multi-disciplinary project teams. The... View Details
Keywords: Service Delivery; Activity Based Costing and Management; Health Care and Treatment; Health Industry
Kaplan, Robert S., Derek A. Haas, Richard A. Helmers, March Rucci, and Meredith Brady. "The Mayo Clinic Model for Running a Value-Improvement Program." Harvard Business Review (website) (October 22, 2015). (A collaboration of the editors of Harvard Business Review and the New England Journal of Medicine.)
- March 2003
- Case
Investing in Japan
By: Peter A. Hecht and Luis M. Viceira
The evolution of the macroeconomic environment, capital markets, financial institutions (including banks, public and private pension funds, and mutual funds), and financial regulation in Japan during the period 1980 to 2002, are examined long-term demographic... View Details
Hecht, Peter A., and Luis M. Viceira. "Investing in Japan." Harvard Business School Case 203-036, March 2003.
- Video
Adrian Gore
Adrian Gore, founder and Group Chief Executive of Discovery Limited, outlines a commitment to improving the health of their customers, which has allowed the company to continue building public trust. View Details
- March 2012
- Article
Macroeconomic Policy and U.S. Competitiveness
By: Richard H.K. Vietor and Matthew Weinzierl
The United States is on a glide path to fiscal disaster, with experts projecting that the federal government will take in far less money than it spends-indefinitely. Our current fiscal policy is eroding competitiveness in several ways, and business conditions in the... View Details
Keywords: Macroeconomics; Government and Politics; Financial Crisis; Policy; Competition; Public Administration Industry; United States
Vietor, Richard H.K., and Matthew Weinzierl. "Macroeconomic Policy and U.S. Competitiveness." Harvard Business Review 90, no. 3 (March 2012).
- April 2019 (Revised June 2019)
- Case
Ariadne Labs: Building Impactful Partnerships
By: Ariel D. Stern and Sarah Mehta
In September 2018, the executive team at Ariadne Labs (Ariadne), a Boston-based organization dedicated to improving health systems through the discovery and implementation of simple tools, faced a number of strategic decisions. Chief among them, the seven-year-old... View Details
Keywords: Health; Health Care and Treatment; Innovation and Invention; Social Enterprise; Nonprofit Organizations; Partners and Partnerships; Health Industry; Boston
Stern, Ariel D., and Sarah Mehta. "Ariadne Labs: Building Impactful Partnerships." Harvard Business School Case 619-017, April 2019. (Revised June 2019.)
- 11 May 2011
- News
Clinical Registries: The Opportunity For The Nation
- 14 Apr 2020
- Video
Perspectives on the COVID-19 Pandemic: Jha-Huckman (Session 2)
- 18 Apr 2024
- Lecture
Innovation Opportunities Created by COVID-19 Can Help: And How to Make Them Happen
The crush of patients created by COVID enabled the creation of sites for care outside the traditional hospital, such as retail pharmacies, ambulatory surgery centers, urgent care centers, telemedicine, and wireless sensors. Public policy mirrored these changes by... View Details
- Article
Lessons from Mayo Clinic's Redesign of Stroke Care
By: Robert S. Kaplan, W. David Freeman, Kevin M. Barrett, Lisa Nordan, Aaron C. Spaulding and Meredith Karney
Facing escalating costs of medications and technology, health care patients and providers in the United States continue to search for opportunities to reduce overall costs while maintaining and improving health care outcomes. The Mayo Clinic Comprehensive Stroke Center... View Details
Kaplan, Robert S., W. David Freeman, Kevin M. Barrett, Lisa Nordan, Aaron C. Spaulding, and Meredith Karney. "Lessons from Mayo Clinic's Redesign of Stroke Care." Special Issue on HBR Insight Center: The Future of Health Care. Harvard Business Review (website) (October 2018).
- June 2006 (Revised June 2007)
- Background Note
The Challenge Facing the U.S. Healthcare Delivery System
By: Richard M.J. Bohmer and Carin-Isabel Knoop
Discusses the challenges currently facing the U.S. health care delivery system. These challenges frame the problems managers of delivery organizations are currently facing. They include a burgeoning gap between demand and supply. Demand for health care services is... View Details
Bohmer, Richard M.J., and Carin-Isabel Knoop. "The Challenge Facing the U.S. Healthcare Delivery System." Harvard Business School Background Note 606-096, June 2006. (Revised June 2007.)
- 15 Sep 2009
- News
Insurance supermarket risks
- September 2023
- Article
Addressing Vaccine Hesitancy: Experimental Evidence from Nine Countries during the COVID-19 Pandemic
By: Vincenzo Galasso, Vincent Pons, Paola Profeta, Martin McKee, David Stuckler, Michael Becher, Sylvain Brouard and Martial Foucault
We study the impact of public health messages on intentions to vaccinate and vaccination uptakes, especially among hesitant groups. We performed an experiment comparing the effects of egoistic and altruistic messages on COVID-19 vaccine intentions and behaviour. We... View Details
Keywords: COVID-19; Vaccination; Vaccine Hesitancy; Information Campaigns; Health Pandemics; Behavior; Information
Galasso, Vincenzo, Vincent Pons, Paola Profeta, Martin McKee, David Stuckler, Michael Becher, Sylvain Brouard, and Martial Foucault. "Addressing Vaccine Hesitancy: Experimental Evidence from Nine Countries during the COVID-19 Pandemic." BMJ Global Health 8, no. 9 (September 2023).
- March 2017
- Case
PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World
By: Kevin Schulman, Sashidaran Moodley and Anant Vasudevan
PharmAccess is an Amsterdam-based NGO working to support the development of the private health care market in Africa. This work is critical as over 50% of care is delivered through the private sector, but well-intentioned efforts to address global health through the... View Details
Keywords: Finance; Entrepreneurship; Health Care and Treatment; Online Technology; Health Industry; Africa; Kenya
Schulman, Kevin, Sashidaran Moodley, and Anant Vasudevan. "PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World." Harvard Business School Case 317-103, March 2017.
John A. Quelch
John A. Quelch is Executive Vice Chancellor and Distinguished Professor of Social Science at Duke Kunshan University. He is also John DeButts Professor at Duke University's Fuqua School of Business. Between 2017 and 2023 he was the Leonard M. Miller University... View Details
- 07 Nov 2020
- News